First Seizures, Acute Repetitive Seizures, and Status Epilepticus

Area of Science:

• Neurology
• Clinical Medicine
• Epilepsy Management

Background:

• The risk of a second seizure after a first unprovoked seizure is significant, particularly with risk factors like EEG abnormalities or brain trauma.
• Acute repetitive seizures require prompt benzodiazepine administration, while established status epilepticus involves phased treatment with benzodiazepines and antiseizure medications.

Purpose of the Study:

• To provide evidence-based guidance on treating unprovoked first seizures in children and adults.
• To outline effective therapies for acute repetitive (cluster) seizures.
• To review the diagnosis and management of established, refractory, and super-refractory status epilepticus.

Main Methods:

• Review of current evidence on seizure management.
• Guidance on therapeutic interventions and dosing for various seizure types.
• Discussion of diagnostic and management strategies for status epilepticus.

Main Results:

• The risk of a second seizure is 36% at 2 years and 46% at 5 years, increased by specific risk factors.
• First-line treatment for established status epilepticus involves benzodiazepines, followed by specific antiseizure medications.
• Equipoise exists for third-phase treatment of refractory status epilepticus between adding a second IV medication or initiating continuous IV infusion.

Conclusions:

• Evidence-based treatment protocols are crucial for managing first seizures and status epilepticus.
• Modern therapies offer effective options for acute and refractory seizure management.
• Artificial intelligence may assist in clinical decision-making post-seizure.